Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013
, Xi Zhang1
, Lili Ren1
, Xuelian Yu1
, Lijuan Chen1
, Hongli Zhou, Xin Gao, Zheng Teng, Jianguo Li, Jiayu Hu, Chao Wu, Xia Xiao, Yiyi Zhu, Quanyi Wang, Xinghuo Pang, Qi Jin2
, Fan Wu2
, and Jianwei Wang2
Author affiliations: MOH Key Laboratory of Systems Biology of Pathogens, Beijing, People’s Republic of China (L. Guo, L. Ren, J. Li, Q. Jin, J. Wang); Institute of Pathogen Biology, Beijing (L. Guo, L. Ren, H. Zhou, X. Gao, J. Li, C. Wu, X. Xiao, Q. Jin, J. Wang); Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People’s Republic of China (X. Zhang, X. Yu, Z. Teng, J. Hu, Y. Zhu, F. Wu); Beijing Municipal Center for Disease Control and Prevention, Beijing (L. Chen, Q. Wang, X. Pang)
Figure 4. Correlation analysis among titers of hemagglutination inhibition (HI), neutralizing antibodies (NAbs), and IgG against H7 in patients infected with influenza A(H7N9) virus, China, 2013A) NAb vsHIB) IgG against H7 vsHIC) NAb vsIgG against H7.
Page created: January 17, 2014
Page updated: January 17, 2014
Page reviewed: January 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.